Jump Financial’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.3M | Buy |
+356,306
| New | +$17.3M | 0.19% | 113 |
|
|
2025
Q1 | – | Sell |
-139,280
| Closed | -$5.48M | – | 1641 |
|
|
2024
Q4 | $5.48M | Buy |
139,280
+88,448
| +174% | +$3.48M | 0.11% | 230 |
|
|
2024
Q3 | $2.39M | Buy |
+50,832
| New | +$2.39M | 0.05% | 447 |
|
|
2024
Q1 | – | Sell |
-42,417
| Closed | -$2.66M | – | 1952 |
|
|
2023
Q4 | $2.66M | Buy |
42,417
+9,110
| +27% | +$570K | 0.08% | 282 |
|
|
2023
Q3 | $1.51M | Buy |
33,307
+22,006
| +195% | +$999K | 0.06% | 478 |
|
|
2023
Q2 | $634K | Sell |
11,301
-111,258
| -91% | -$6.25M | 0.02% | 911 |
|
|
2023
Q1 | $5.54M | Buy |
122,559
+67,372
| +122% | +$3.05M | 0.23% | 133 |
|
|
2022
Q4 | $2.24M | Buy |
+55,187
| New | +$2.24M | 0.12% | 239 |
|
|
2022
Q2 | – | Sell |
-6,343
| Closed | -$398K | – | 1682 |
|
|
2022
Q1 | $398K | Buy |
+6,343
| New | +$398K | 0.02% | 920 |
|
|
2021
Q4 | – | Sell |
-2,865
| Closed | -$320K | – | 1437 |
|
|
2021
Q3 | $320K | Buy |
+2,865
| New | +$320K | 0.02% | 634 |
|
|
2021
Q2 | – | Sell |
-5,300
| Closed | -$646K | – | 1132 |
|
|
2021
Q1 | $646K | Buy |
+5,300
| New | +$646K | 0.06% | 342 |
|